• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe

Latest News on MassDevice

Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure

September 18, 2026 By Conor Hale

Analysts at Citigroup bowed to the uncertainty surrounding Boston Scientific’s (NYSE:BSX) immediate financial future, delivering a downgrade to its stock rating as headwinds in its cardiac business are complicated by its recovery from a major cyberattack last month. Citi’s researchers have lowered their estimates for the company eight times so far this year, most recently […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Featured, Pulsed-Field Ablation (PFA), Structural Heart, Structural Heart, Wall Street Beat Tagged With: Boston Scientific, Citigroup, financial

Autonomix taps former Medtronic FDA counsel head for board of directors

September 18, 2026 By Conor Hale

Autonomix Medical (Nasdaq:AMIX) has tapped Medtronic’s former chief regulatory counsel, Sandra Cohen Kalter, for its board of directors as it looks to advance its pipeline of catheters for mapping and treating the nervous system. Kalter has served as an advisor to Autonomix’s board for nearly a year. Now with her own seat, the company hopes […]

Filed Under: Business/Financial News, Neurological, Pain Management, Regulatory/Compliance Tagged With: Autonomix, Autonomix Medical, Medtronic, Personnel Moves

Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say

September 18, 2026 By Conor Hale

While some industry watchers have declared Medtronic’s (NYSE:MDT) recent marquee investment in Cornerstone Robotics a sign of wavering confidence in its homegrown Hugo platform, analysts say a closer look holds the potential of a broader customer base and stronger strategic position. In a note to investors, Needham & Co. analysts agreed with Medtronic’s pitch that […]

Filed Under: Business/Financial News, Emerging Markets, Featured, Hospital Care, Robotic-Assisted, Surgical, Surgical Robotics Tagged With: Cornerstone Robotics, Medtronic, Morgan Stanley, Needham & Co., Robotic Surgery, surgical robot, Wells Fargo

Science Corp. names president as it looks to roll out vision-restoring implant

September 17, 2026 By Conor Hale

Science Corp. has promoted its chief strategy officer to become its new president. The brain-computer interface company said Darius Shahida would continue his previous work leading its global commercialization and partnership efforts, following the European launch this summer of its Prima implant for restoring vision in patients with age-related macular degeneration, or AMD. In July, […]

Filed Under: Bioelectronic Medicine, Brain-Computer Interface (BCI), Digital Health, Implants, Vision Tagged With: blindness, brain-computer interface, Science Corporation

Mindray looks to fill hospital ventilator gap left by Philips’ exit

September 17, 2026 By Conor Hale

Mindray is rolling out a new model in its hospital ventilator lineup, following the exits of major medtechs in the respiratory care sector, including Philips and Medtronic. According to the company, the SV70 allows clinicians to switch between non-invasive ventilation and integrated high-flow oxygen therapy. The system is currently available in the U.S., with demonstrations […]

Filed Under: Featured, Hospital Care, Patient Monitoring, Respiratory Tagged With: Medtronic, Mindray Medical International Ltd., Philips, Philips Respironics, ventilators

Johnson & Johnson drops LAA assets following suspended pivotal study

September 17, 2026 By Conor Hale

Johnson & Johnson MedTech (NYSE:JNJ) is offloading a left-atrial appendage closure system it paid $400 million upfront for nearly three years ago, abandoning plans to compete in the space dominated by Boston Scientific and Abbott. Acquired through its late-2023 buy of the developer Laminar, J&J’s Biosense Webster then backed a pivotal study that sought to […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Implants, Mergers & Acquisitions, Structural Heart, Structural Heart Tagged With: Johnson & Johnson, Laminar, Sante Ventures

Neptune Medical’s robotic colonoscopy system obtains FDA clearance

September 16, 2026 By Conor Hale

Neptune Medical has landed an FDA clearance for its robotic system designed to provide stable control during colonoscopy. The Triton 1 flexible endoscopy system is designed to reach anywhere within the colon for both diagnostic and therapeutic procedures, including screenings for colorectal cancer as well as the removal of early-stage tumors and precancerous growths. According […]

Filed Under: 510(k), Endoscopic, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Robotic-Assisted, Surgical Robotics Tagged With: bowel cancer, Cancer, Colonoscopy, FDA, Neptune Medical, Robotic Surgery

Medtronic grabs FDA clearance to add LigaSure vessel sealer to Hugo

September 16, 2026 By Conor Hale

Medtronic (NYSE: MDT) has received an FDA green light to bring its vessel-sealing technology over to its Hugo surgical robot, adding to the platform’s U.S. catalog of energy instruments. The agency’s clearance covers the first version of the LigaSure Maryland jaw device designed specifically for robotic-assisted surgery. According to Medtronic, the hand-held vessel sealer has […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Men's Health, Regulatory/Compliance, Robotic-Assisted, Surgical, Surgical Robotics, Urology Tagged With: FDA, Medtronic, Robotic Surgery, surgical robot

Paradromics’ first study participant uses BCI for real-time speech

September 15, 2026 By Conor Hale

Paradromics demonstrated that its brain-computer interface implant could enable real-time speech communication, with its first early study participant able to choose her own words and answer open-ended questions. The woman received a diagnosis of a progressive motor neuron disease about 10 years ago, in a group of conditions that includes amyotrophic lateral sclerosis and primary […]

Filed Under: Artificial Intelligence (AI), Brain-Computer Interface (BCI), Clinical Trials, Digital Health, Featured, Neurological Tagged With: ALS, brain-computer interface, paradromics

Medtronic hires former Recor CEO to run interventional cardiology group

September 15, 2026 By Jim Hammerand

Medtronic (NYSE:MDT) has hired former Recor Medical President and CEO Lara Barghout as president of the Interventional Cardiology Therapies (ICT) operating unit. The ICT business covers minimally invasive therapies in structural heart, coronary, and hypertension management, the last of which includes renal denervation (RDN). Watch on-demand: The 2026 MDO Min-Vasive Medtech webinar series Recor Medical won […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Catheters, Featured, News Well, Replacement Heart Valves, Structural Heart Tagged With: Medtronic, Personnel Moves, ReCor Medical, renal denervation, Women in Medtech

Abbott wins FDA approval for Aveir VR Mini ventricular leadless pacemaker

September 15, 2026 By Chris Newmarker

Abbott (NYSE: ABT) announced today that the FDA has approved the smallest version yet of its Aveir leadless pacemakers. The Aveir VR Mini ventricular leadless pacemaker is 32.5 mm long, a 14% reduction from the 38.0 mm of the existing Aveir VR ventricular leadless pacemaker. According to Abbott, it designed the system to deliver longevity […]

Filed Under: Cardiovascular, Featured, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Abbott

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 4642
  • Go to Next Page »

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy